This webinar delivers a critical update on the 2025 interim final rule for HIPAA compliance under Administrative Simplification. The rule introduces new compliance timelines and transition periods that will significantly impact healthcare operations, particularly in retail pharmacy and Medicaid pharmacy subrogation. The effective date was April 14, 2025, with a full compliance deadline of April 14, 2028—making it essential for covered entities to begin preparations now.

We will cover the updated transaction standards. For retail pharmacy, this includes the mandatory move from Versions D.0 and 1.2 to the new Versions F6 and 15 for electronic transactions such as claims, eligibility, and referrals. For state Medicaid agencies, we will explain the required transition from Version 3.0 to Version 10 for pharmacy subrogation. The session will also clarify the 8-month transition period, starting August 14, 2027, when dual versions may be used before the final cutover.

Additionally, we will discuss the technical corrections made in the rule and explain how the January 2025 Presidential regulatory freeze influenced the adjusted timeline. Participants will gain practical strategies for readiness, including vendor coordination, system testing, and audit documentation to avoid disruptions. We will also review the projected cost savings and regulatory relief outlined in the rule, particularly for smaller entities and rural hospitals, while confirming that no new reporting burdens are introduced. The message is clear: the deadlines are firm, and proactive planning is essential for successful adoption of the updated HIPAA standards.

The U.S. Department of Health and Human Services (HHS) issued this interim final rule to modify compliance dates and transition requirements for mandated electronic transaction standards. These updates specifically affect retail pharmacy and Medicaid pharmacy subrogation, setting deadlines that covered entities must meet to maintain medical compliance.

Outline:

The countdown to the 2028 deadline for new transaction standards is already underway. Failure to prepare could result in operational breakdowns, denied claims, and costly penalties. Are your systems and vendor agreements aligned with NCPDP changes, or will you risk compliance gaps, financial loss, and interoperability issues during the transition?

Areas Covered:

• A detailed look at the updated compliance timelines, including the 2025 effective date and 2028 final deadline.
• Specific requirements for retail pharmacy to move from Versions D.0 and 1.2 to F6 and 15.
• Guidance for Medicaid agencies on transitioning from Version 3.0 to Version 10 for pharmacy subrogation.
• Clarification of technical corrections, the 8-month dual-use transition period, and the effect of the regulatory freeze.
• Strategies for readiness, including vendor coordination, risk mitigation, system testing, and audit documentation.
• An overview of regulatory impact, projected cost savings, and relief measures for small entities.

Why Should You Attend:

Understanding the details of this interim final rule is critical for a smooth transition. This webinar provides a clear roadmap for navigating the updated timeline, preparing for new retail pharmacy requirements, and managing Medicaid pharmacy subrogation changes. Attending will equip you with the tools to ensure your systems are ready, mitigate risks, and protect healthcare privacy. We will break down complex requirements into actionable strategies, helping your organization avoid disruptions, claim rejections, and penalties.

Who Should Attend:

• Healthcare Compliance Officers
• IT Leads and System Administrators
• Medicaid Administrators
• Pharmacy Benefit Managers (PBMs)
• Healthcare Revenue Cycle Managers
• Health Information Management (HIM) Professionals.